Poly Medicure Limited (NSE:POLYMED)
India
· Delayed Price · Currency is INR 2,359.80
-64.70 (-2.67%)
May 14, 2025, 3:29 PM IST
Poly Medicure Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 16,698 | 13,758 | 11,152 | 9,231 | 7,865 | Upgrade
|
| Revenue Growth (YoY) | 21.37% | 23.36% | 20.82% | 17.37% | 14.44% | Upgrade
|
| Cost of Revenue | 5,547 | 4,867 | 4,090 | 3,506 | 2,636 | Upgrade
|
| Gross Profit | 11,151 | 8,891 | 7,062 | 5,724 | 5,229 | Upgrade
|
| Selling, General & Admin | 3,015 | 2,516 | 2,076 | 1,671 | 1,448 | Upgrade
|
| Research & Development | 245.71 | 189.6 | 178.03 | 187.71 | 131.45 | Upgrade
|
| Other Operating Expenses | 3,362 | 2,584 | 2,109 | 1,730 | 1,506 | Upgrade
|
| Operating Expenses | 7,449 | 5,928 | 4,934 | 4,128 | 3,560 | Upgrade
|
| Operating Income | 3,702 | 2,963 | 2,128 | 1,596 | 1,669 | Upgrade
|
| Interest Expense | -119.97 | -109.34 | -62.27 | -38.28 | -69.84 | Upgrade
|
| Interest & Investment Income | - | 118.36 | 153.29 | 94.75 | 43.03 | Upgrade
|
| Earnings From Equity Investments | 51.8 | 25.27 | 19.27 | 24.47 | 33.11 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 152.83 | 113.82 | 118.84 | 67.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 891.28 | 62.4 | 62.26 | 55.11 | 23.2 | Upgrade
|
| EBT Excluding Unusual Items | 4,525 | 3,212 | 2,414 | 1,851 | 1,765 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 209.49 | -40.07 | 96 | 35.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 6.23 | 1 | 5.31 | 0.07 | Upgrade
|
| Other Unusual Items | - | 14.53 | - | - | - | Upgrade
|
| Pretax Income | 4,525 | 3,443 | 2,375 | 1,952 | 1,801 | Upgrade
|
| Income Tax Expense | 1,140 | 860.09 | 582.09 | 487.39 | 441.8 | Upgrade
|
| Net Income | 3,386 | 2,583 | 1,793 | 1,465 | 1,359 | Upgrade
|
| Net Income to Common | 3,386 | 2,583 | 1,793 | 1,465 | 1,359 | Upgrade
|
| Net Income Growth | 31.09% | 44.05% | 22.37% | 7.83% | 41.72% | Upgrade
|
| Shares Outstanding (Basic) | 99 | 96 | 96 | 96 | 89 | Upgrade
|
| Shares Outstanding (Diluted) | 99 | 96 | 96 | 96 | 89 | Upgrade
|
| Shares Change (YoY) | 3.37% | - | 0.06% | 7.64% | 0.99% | Upgrade
|
| EPS (Basic) | 34.13 | 26.92 | 18.69 | 15.28 | 15.25 | Upgrade
|
| EPS (Diluted) | 34.11 | 26.90 | 18.67 | 15.27 | 15.24 | Upgrade
|
| EPS Growth | 26.80% | 44.08% | 22.27% | 0.20% | 40.33% | Upgrade
|
| Free Cash Flow | -906.06 | -109.34 | -482.23 | -321.06 | 236.01 | Upgrade
|
| Free Cash Flow Per Share | -9.13 | -1.14 | -5.02 | -3.35 | 2.65 | Upgrade
|
| Dividend Per Share | 3.500 | 3.000 | 3.000 | 2.500 | 2.500 | Upgrade
|
| Dividend Growth | 16.67% | - | 20.00% | - | 25.00% | Upgrade
|
| Gross Margin | 66.78% | 64.63% | 63.32% | 62.02% | 66.49% | Upgrade
|
| Operating Margin | 22.17% | 21.54% | 19.08% | 17.29% | 21.22% | Upgrade
|
| Profit Margin | 20.28% | 18.77% | 16.08% | 15.87% | 17.28% | Upgrade
|
| Free Cash Flow Margin | -5.43% | -0.80% | -4.32% | -3.48% | 3.00% | Upgrade
|
| EBITDA | 4,534 | 3,577 | 2,677 | 2,118 | 2,125 | Upgrade
|
| EBITDA Margin | 27.15% | 26.00% | 24.01% | 22.94% | 27.02% | Upgrade
|
| D&A For EBITDA | 831.82 | 614.02 | 549.8 | 521.67 | 456.63 | Upgrade
|
| EBIT | 3,702 | 2,963 | 2,128 | 1,596 | 1,669 | Upgrade
|
| EBIT Margin | 22.17% | 21.54% | 19.08% | 17.29% | 21.22% | Upgrade
|
| Effective Tax Rate | 25.18% | 24.98% | 24.51% | 24.96% | 24.54% | Upgrade
|
| Revenue as Reported | 17,590 | 14,345 | 11,514 | 9,610 | 8,049 | Upgrade
|
| Advertising Expenses | - | 33.91 | 28.51 | 12.89 | 8.02 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.